Related references
Note: Only part of the references are listed.Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells
A. Tchoghandjian et al.
CELL DEATH & DISEASE (2013)
The Role of Decitabine for the Treatment of Acute Myeloid Leukemia
Alex Ganetsky
ANNALS OF PHARMACOTHERAPY (2012)
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Liming Sun et al.
CELL (2012)
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
L. Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2012)
RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis
S. Loeder et al.
LEUKEMIA (2012)
Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies
S. Fulda
LEUKEMIA (2012)
Targeting IAP proteins for therapeutic intervention in cancer
Simone Fulda et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production
N. Vanlangenakker et al.
CELL DEATH AND DIFFERENTIATION (2011)
Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis
Federica Servida et al.
INVESTIGATIONAL NEW DRUGS (2011)
Deregulated apoptosis signaling in core-binding factor leukemia differentiates clinically relevant, molecular marker-independent subgroups
S. C. Lueck et al.
LEUKEMIA (2011)
Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis
Andrew Oberst et al.
NATURE (2011)
Smac Mimetic Bypasses Apoptosis Resistance in FADD- or Caspase-8-Deficient Cells by Priming for Tumor Necrosis Factor α-Induced Necroptosis
Bram Laukens et al.
NEOPLASIA (2011)
Smac mimetics: implications for enhancement of targeted therapies in leukemia
E. Weisberg et al.
LEUKEMIA (2010)
5-Aza-2′-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis
Benigno C. Valdez et al.
LEUKEMIA RESEARCH (2010)
Targeting mitochondria for cancer therapy
Simone Fulda et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Molecular mechanisms of necroptosis: an ordered cellular explosion
Peter Vandenabeele et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Cell death in hematological tumors
Simone Fulda
APOPTOSIS (2009)
Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia
Meike Vogler et al.
BLOOD (2009)
Apoptosis in leukemia: From molecular pathways to targeted therapies
Aaron D. Schimmer
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
TNF-α induces two distinct caspase-8 activation pathways
Lai Wang et al.
CELL (2008)
A novel effect of DNA methyltransferase and histone deacetylase inhibitors -: NFκB inhibition in malignant myeloblasts
Claire Fabre et al.
CELL CYCLE (2008)
Targeting the extrinsic apoptosis pathway in cancer
Avi Ashkenazi
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation
Eugene Varfolomeev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination
Mathieu J. M. Bertrand et al.
MOLECULAR CELL (2008)
Acute Myeloid Leukemia-Targeted Toxin Activates Both Apoptotic and Necroptotic Death Mechanisms
Henrick Horita et al.
PLOS ONE (2008)
Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)
Amanda F. Cashen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis
Eugene Varfolomeev et al.
CELL (2007)
IAP antagonists target cIAP1 to induce TNFα- dependent apoptosis
James E. Vince et al.
CELL (2007)
Autocrine TNFα signaling renders human cancer cells susceptible to smac-mimetic-induced apoptosis
Sean L. Petersen et al.
CANCER CELL (2007)
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia
William Blum et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia
Lars Bullinger et al.
BLOOD (2007)
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells
Ellen Weisberg et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Activated intrinsic apoptosis pathway is a key related prognostic parameter in acute myeloid leukemia
Corine J. Hess et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Mitochondrial membrane permeabilization in cell death
Guido Kroemer et al.
PHYSIOLOGICAL REVIEWS (2007)
Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family
Brendan P. Eckelman et al.
EMBO REPORTS (2006)
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
S. Fulda et al.
ONCOGENE (2006)
Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells
BZ Carter et al.
BLOOD (2005)
Bioavailability of azacitidine subcutaneous versus intravenous in patients with the myelodysplastic syndromes
G Marcucci et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis
I Tamm et al.
HEMATOLOGY JOURNAL (2004)
Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis
S Fulda et al.
ONCOGENE (2001)
Share Paper
